• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “impossible-foods” Archives

          in
          Entry Author Date Location
          Motif Unveils New Name and $27.5M to Build Food Ingredients Pipeline Frank Vinluan 08/15/19 Boston
          Record Exit Value for VC-Backed Startups Could Fuel Investment Sarah de Crescenzo 07/11/19 National
          Beyond Meat’s IPO Bags $241M to Make Plant-Based Burgers Mainstream Frank Vinluan 05/02/19 National
          Ginkgo’s Motif Launches with $90M for Animal-Free Meat & Milk Proteins Frank Vinluan 02/26/19 Boston
          Plant-Based Burger Maker Beyond Meat Cooks Up Plans for an IPO Frank Vinluan 11/19/18 National
          Andreessen Horowitz Backs Asimov’s Synthetic Biology CAD Software Jeff Bauter Engel 12/19/17 Boston
          Ginkgo Bioworks Pulls In $275M as Synthetic Biology Funding Soars Jeff Bauter Engel 12/14/17 Boston
          Memphis Meats Cooks Up $17M Funding Round for Lab-Grown “Meat” Frank Vinluan 08/23/17 San Francisco
          Impossible Foods Lands $108,000,000 Series D Funding VentureDeal 10/07/15 San Francisco
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • How Big Is the US Market for Medical Devices & Technologies?

            Sponsored · Whitepaper

            How Big Is the US Market for Medical Devices & Technologies?

            Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product

            IBM Watson
          • Potency Assay Development for Cell and Gene Therapy Products

            Sponsored · Whitepaper

            Potency Assay Development for Cell and Gene Therapy Products

            Create well-controlled, biologically relevant test systems and validate them to support FDA approvals

            Absorption Systems
          • How to Approach Life Sciences Fundraising

            Sponsored · Whitepaper

            How to Approach Life Sciences Fundraising

            Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research

            Brex

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.